Gain Therapeutics, Inc. (GANX) NASDAQ
1.83
-0.13(-6.63%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.83
-0.13(-6.63%)
Currency In USD
| Market Cap | 106.16M |
| Enterprise Value | 86.05M |
| P/E Ratio | -3.64 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 5.52 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.15 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.13 |
| Return On Equity | -2.01 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -18.62M |
| Net Income | -20.16M |
| Diluted EPS | -0.61 |
| Total Cash | 16.54M |
| Total Cash/Share | 0.39 |
| Total Debt | 298,756 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 4.69 |
| Book Value Per Share | 0.33 |
| 52-Week Change | -5.18 |
| 52-Week High | 4.34 |
| 52-Week Low | 1.41 |
| Moving Average 50 Days | 1.87 |
| Moving Average 200 Days | 2.2 |
| Average Volume | 685,434 |
| Shares Outstanding | 42.65M |
| % Held by Institutions | 24.86 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |